Insights

Expanding Global Presence Leap Therapeutics is developing DKN-01 in Asia through a strategic agreement with BeiGene, Ltd., indicating opportunities for expansion and growth in the Asian market.

Strategic Acquisitions Recent acquisitions of Biopharmadive and Flame Biosciences showcase Leap Therapeutics' commitment to enhancing its portfolio and capabilities, providing potential partnership opportunities for new product developments.

Clinical Study Initiatives The initiation of the randomized controlled Part B of the DeFianCe study of DKN-01 in colorectal cancer patients demonstrates Leap Therapeutics' active engagement in clinical research, presenting collaboration prospects with healthcare institutions and researchers.

Tech-Driven Innovations Utilizing a tech stack that includes Microsoft Excel, jQuery, and Adobe Tag Manager, Leap Therapeutics shows a focus on innovation, offering opportunities for technology partnerships and solutions providers to collaborate on research and development projects.

Financial Stability and Investment With a revenue range of $0-10M and secured funding of $40M, Leap Therapeutics exhibits financial stability and potential for investors seeking opportunities in the biotechnology sector.

Similar companies to Leap Therapeutics

Leap Therapeutics Tech Stack

Leap Therapeutics uses 8 technology products and services including Microsoft Excel, RequireJS, Prototype, and more. Explore Leap Therapeutics's tech stack below.

  • Microsoft Excel
    Editors
  • RequireJS
    Javascript Frameworks
  • Prototype
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • HSTS
    Security
  • Adobe Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks

Media & News

Leap Therapeutics's Email Address Formats

Leap Therapeutics uses at least 1 format(s):
Leap Therapeutics Email FormatsExamplePercentage
FLast@leaptx.comJDoe@leaptx.com
49%
Last@leaptx.comDoe@leaptx.com
2%
FLast@leaptx.comJDoe@leaptx.com
49%

Frequently Asked Questions

Where is Leap Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Leap Therapeutics's main headquarters is located at 47 Thorndike St, Suite B1-1 Cambridge, MA 02141 US. The company has employees across 2 continents, including North AmericaEurope.

What is Leap Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Leap Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Leap Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Leap Therapeutics is a publicly traded company; the company's stock symbol is LPTX.

What is Leap Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Leap Therapeutics's official website is leaptx.com and has social profiles on LinkedIn.

How much revenue does Leap Therapeutics generate?

Minus sign iconPlus sign icon
As of November 2024, Leap Therapeutics's annual revenue reached $7.5M.

What is Leap Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Leap Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Leap Therapeutics have currently?

Minus sign iconPlus sign icon
As of November 2024, Leap Therapeutics has approximately 48 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: D. O.Chief Scientific Officer: J. B.Chief Medical Officer: C. S.. Explore Leap Therapeutics's employee directory with LeadIQ.

What industry does Leap Therapeutics belong to?

Minus sign iconPlus sign icon
Leap Therapeutics operates in the Biotechnology Research industry.

What technology does Leap Therapeutics use?

Minus sign iconPlus sign icon
Leap Therapeutics's tech stack includes Microsoft ExcelRequireJSPrototypejQueryOpen GraphHSTSAdobe Tag ManagerBootstrap.

What is Leap Therapeutics's email format?

Minus sign iconPlus sign icon
Leap Therapeutics's email format typically follows the pattern of . Find more Leap Therapeutics email formats with LeadIQ.

How much funding has Leap Therapeutics raised to date?

Minus sign iconPlus sign icon
As of November 2024, Leap Therapeutics has raised $40M in funding. The last funding round occurred on Apr 10, 2024 for $40M.
Leap Therapeutics

Leap Therapeutics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.

For more information about Leap Therapeutics, visit http://www.leaptx.com or our public filings with the SEC that are available via EDGAR at http://www.sec.gov or via http://www.investors.leaptx.com.

Section iconCompany Overview

Headquarters
47 Thorndike St, Suite B1-1 Cambridge, MA 02141 US
Phone number
Website
leaptx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
LPTX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $40M

    Leap Therapeutics has raised a total of $40M of funding over 10 rounds. Their latest funding round was raised on Apr 10, 2024 in the amount of $40M.

  • $10M

    Leap Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $40M

    Leap Therapeutics has raised a total of $40M of funding over 10 rounds. Their latest funding round was raised on Apr 10, 2024 in the amount of $40M.

  • $10M

    Leap Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.